BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 3
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study
©Author(s) (or their employer(s)) 2026.
World J Psychiatry. Mar 19, 2026; 16(3): 112418
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.112418
Figure 2
Full Size Figure Download Figure
Figure 2 Serum folate and brain-derived neurotrophic factor levels across different severity grades in the research group. A: Serum folate concentrations in mild, moderate, and severe patients; B: Brain-derived neurotrophic factor concentrations in cases with mild, moderate, or severe illness. bP < 0.01; cP < 0.001. SF: Serum folate; BDNF: Brain-derived neurotrophic factor.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.